Added value of serial bio-adrenomedullin measurement in addition to lactate for the prognosis of septic patients admitted to ICU
Main Authors: | Alice Blet, Charles de Roquetaillade, Oliver Hartmann, Joachim Struck, Alexandre Mebazaa, Benjamin Glenn Chousterman, on behalf of the Adrenoss-1 study investigators |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | Critical Care |
Online Access: | http://link.springer.com/article/10.1186/s13054-020-2794-x |
Similar Items
-
Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study
by: Alexandre Mebazaa, et al.
Published: (2018-12-01) -
Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: Post-hoc analyses of the phase II adrenomedullin and outcome in septic shock 2 trial
by: Dirk van Lier, et al.
Published: (2022-12-01) -
Adrecizumab, a non-neutralizing anti-adrenomedullin antibody, improves haemodynamics and attenuates myocardial oxidative stress in septic rats
by: Alice Blet, et al.
Published: (2019-05-01) -
Lactate / albumin ratio as prognostic tool for risk stratification in septic patients admitted to ICU.
by: Vasant Mourya, et al.
Published: (2023-12-01) -
Protracted immune disorders at one year after ICU discharge in patients with septic shock
by: Florence Riché, et al.
Published: (2018-02-01)